Biggest News Aggregation in the World
📰 Segments Profiled News

Page 21 - Segments Profiled News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Segments Profiled. Real-time updates on events, politics, business and more.

Hematopoietic Stem Cell Transplantation Market is expected to grow at a CAGR of 7.5% from 2023 to 20

A recently published study by FMI expects the global hematopoietic stem cell transplantation market to augment at an 8% CAGR from 2023 to 2033. By the end of the said assessment period, a valuation of US$ 15 Billion is expected for the market. The hematopoietic stem cell transplantation market has grown fast in rece...
United Arab Emirates New York United States Asia Pacific Cellgenix Gmb Hematopoietic Stem Cell Transplantation Market Industry

Surgical Treatment to Possess 60% Market Share for Chiari Malformation Treatment Market | FMI Study

During the forecast period 2023 to 2033, the Chiari malformation treatment market is expected to grow at a value of 6.4% CAGR, according to Future Market Insights. By the year 2033, the global market for Chiari malformation treatment is expected to rise up to a market valuation of US$ 4.2 Billion. Growth of the mark...
United Arab Emirates New York United States Roche Ltd Pfizer Inc Research Institutes

Lung Cancer to Procure 35% Oncolytic Adenovirus Market | FMI Study

During the forecast period 2023 to 2033, the oncolytic adenovirus market is expected to grow at a value of 7.5% CAGR, according to Future Market Insights. By the year 2033, the global market for oncolytic adenovirus is expected to rise up to a market valuation of US$ 250 Billion. Growth of the market can be attribut...
United Arab Emirates United States New York Oncolys Biopharma Lokon Pharma Rd Riikka Havunen

IgA Nephropathy Market is expected to grow at a 7.5% CAGR from 2023 to 2033 | FMI Analyst

According to Future Market Insights, the IgA Nephropathy Market is predicted to increase at a 7.5% CAGR between 2023 and 2033. By the year 2033, the global market for IgA nephropathy is predicted to reach a value of US$ 85 billion.Key factors such as the high frequency of renal illnesses, expanding R&D efforts, incr...
New York United States Asia Pacific Key Companies Novartis Pharmaceuticals Greater New York Chamber

Wilson's Disease Diagnostics Market is expected to grow with a 3.9% CAGR during 2023 to 2033 | FMI Study

During the forecast period 2023 to 2033, Wilson’s Disease Diagnostics Market is expected to grow at a value of 3.9% CAGR, according to Future Market Insights. By the year 2033, the global market for Wilson’s disease diagnostics is expected to rise up to a market valuation of US$ 896 Million.The global market for Wil...
New York United States Europe Wilson Wilson Disease Diagnostics Industry Noblepharma Co Ltd Teva Pharmaceuticals

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Fucosidosis Therapeutics Market is expected to grow with a 6% CAGR during 2023 to 2033 | FMI Report

The global Fucosidosis Therapeutics Market is expected to garner a market value of US$ 10 Million in 2023 and is expected to accumulate a market value of US$ 17.91 Million by registering a CAGR of 6% in the forecast period 2023 to 2033. The market for Fucosidosis Therapeutics registered a CAGR of 4% in the historica...
New York United States Ambergen Hi Asia Pacific Epitope Diagnostics Inc Fucosidosis Therapeutics Industry

Intracardiac Imaging Market size is expected to reach US$ 1256.3 Million by 2032

[Report of 250 Pages] By 2032, it is anticipated that the intracardiac imaging market will be worth US$ 1256.3 million. An increase in the prevalence of arrhythmia, which affects about 500,000 people worldwide, is what is driving the growth of the global intracardiac imaging market.The global intracardiac imaging ma...
United Arab Emirates Plot No Murmanskaya Oblast New Zealand South Korea United States

Next Generation Immunotherapies Market is expected to reach a valuation of US$ 268.84 billion by 203

The global Next Generation Immunotherapies Market is estimated to exceed a spectacular valuation of US$ 268.84 billion in 2033, with a compound annual growth rate (CAGR) of 7.5% projected from 2023 to 2033.The vast majority of present immunotherapies, such as checkpoint inhibitors, seek to enhance the immune system’...
New York United States Mereo Biopharma Huabo Biopharm Key Companies Novacell Technology Inc

Thoracolumbar Stabilization Devices Market is anticipated to account for US$ 2,007.7 million by 2032

The global thoracolumbar stabilisation devices market is expected to be valued at US$ 2,007.7 million by 2032, up from US$ 1,149.6 million in 2022, with a 5.2% CAGR from 2022 to 2032. Thoracolumbar refers to the thoracic and lumbar spine regions. Thoracolumbar stabilisation devices are used to lessen or eliminate sp...
United Arab Emirates United States New York B Braun Melsungen Asia Pacific Medyssey Co

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science